R. Canales

Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension

V. Novack, S. Holland, E. Levy, 2018, Hepatology communications.

A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study

C. Yurdaydın, J. Glenn, H. Dahari, 2017 .